Peptide Tertiary Amide Synthesis for Protein Ligands

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for creating large, high-quality combinatorial libraries of peptide-like oligomers struggle with restricted rotation about the carbonyl-Cα and Cα-nitrogen bonds, limiting protein interactions and affinity.

Innovation Solution

The development of peptide tertiary amides (PTAs) with restricted conformations, synthesized through a sub-monomer route using optically pure 2-bromo acids and primary amines, allowing for Cα- and N-substitutions and enabling high-affinity protein ligands.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If peptoid libraries are synthesized using standard protocols, then large combinatorial libraries can be created easily, but the molecules exhibit high conformational flexibility resulting in low protein binding affinity

Engineering Contradiction:
Improvelibrary synthesis efficiencyVSAvoidprotein binding affinity
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent changes the chemical structure parameter by replacing the standard peptoid amide bond with a tertiary amide bond containing a methyl group at the nitrogen position. This structural modification restricts conformational flexibility while maintaining the ease of library synthesis through solid-phase chemistry, thereby improving protein binding affinity without sacrificing productivity

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention creates a hybrid molecule combining features of peptides (conformational restriction through N-methylation) and peptoids (ease of synthesis, cell permeability). This composite structure achieves both high binding affinity and practical synthesizability for large combinatorial libraries

Inventive Principle:
Principle #40Composite materials

2Reliability

If N-methylated peptides are used, then cell permeability and stability are improved, but only methyl substituents can be used limiting library diversity

Engineering Contradiction:
Improvecell permeability and stabilityVSAvoidsubstituent diversity
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent creates a universal platform where the N-methylated tertiary amide backbone provides consistent cell permeability and stability, while the R1 and R2 substituents can be varied independently to create diverse libraries. This multi-functional design allows the same core structure to serve both stability and diversity requirements

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Ease of operation

If rotation about carbonyl-Cα and Cα-nitrogen bonds is allowed, then molecular flexibility is maintained, but entropic penalty increases limiting binding affinity

Engineering Contradiction:
Improvemolecular flexibilityVSAvoidbinding affinity
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The patent changes the rotational barrier parameter by introducing the N-methyl group in the tertiary amide bond. This increases the energy difference between cis and trans amide bond isomers, effectively restricting rotation and reducing conformational flexibility. The result is lower entropic penalty upon binding while maintaining necessary molecular flexibility for target engagement

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS10370409B2Synthesis of libraries of peptide tertiary amides
Publication Date: 2019.08.06 UNIV OF FLORIDA RESEARCH FOUNDATION INC
  • US10370409B2 patent drawing
  • US10370409B2 patent drawing
  • US10370409B2 patent drawing

AI summary

The present disclosure is directed to a novel class of peptide-like oligomers called peptide tertiary amides (PTAs) and a combinatorial library of PTAs along with synthetic routes for the preparation of large combinatorial libraries of these compounds. The peptide tertiary amides provide an exceptional source of high affinity and selective protein ligands that are useful as tools for biological research and as drug leads, among others.